The latest closing stock price for Cue Biopharma as of September 18, 2024 is 0.55.
An investor who bought $1,000 worth of Cue Biopharma stock at the IPO in 2018 would have $-952 today, roughly -1 times their original investment - a -35.27% compound annual growth rate over 7 years.
The all-time high Cue Biopharma stock closing price was 30.73 on June 02, 2020.
The Cue Biopharma 52-week high stock price is 3.25, which is 490.9% above the current share price.
The Cue Biopharma 52-week low stock price is 0.54, which is 1.8% below the current share price.
The average Cue Biopharma stock price for the last 52 weeks is 1.82.
An investor who bought $1,000 worth of Cue Biopharma stock at the IPO in 2018 would have $-952 today, roughly -1 times their original investment - a -35.27% compound annual growth rate over 7 years.
The all-time high Cue Biopharma stock closing price was 30.73 on June 02, 2020.
The Cue Biopharma 52-week high stock price is 3.25, which is 490.9% above the current share price.
The Cue Biopharma 52-week low stock price is 0.54, which is 1.8% below the current share price.
The average Cue Biopharma stock price for the last 52 weeks is 1.82.